Use of ECMO for Cardiogenic Shock in Pediatric Population.
Priya BhaskarSamuel DavilaAparna HoskoteRavi ThiagarajanPublished in: Journal of clinical medicine (2021)
In children with severe advanced heart failure where medical management has failed, mechanical circulatory support in the form of veno-arterial extracorporeal membrane oxygenation (VA ECMO) or ventricular assist device represents life-sustaining therapy. This review provides an overview of VA ECMO used for cardiovascular support including medical and surgical heart disease. Indications, contraindications, and outcomes of VA ECMO in the pediatric population are discussed.VA ECMO provides biventricular and respiratory support and can be deployed in rapid fashion to rescue patient with failing physiology. There have been advances in conduct and technologic aspects of VA ECMO, but survival outcomes have not improved. Stringent selection and optimal timing of deployment are critical to improve mortality and morbidity of the patients supported with VA ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- heart failure
- respiratory failure
- healthcare
- mechanical ventilation
- end stage renal disease
- young adults
- metabolic syndrome
- prognostic factors
- type diabetes
- early onset
- stem cells
- chronic kidney disease
- case report
- intensive care unit
- bone marrow
- patient reported outcomes
- coronary artery disease
- mesenchymal stem cells
- smoking cessation
- replacement therapy
- sensitive detection